Wolverine Asset Management’s NLS Pharmaceutics Warrant NLSPW Stock Holding History

Wolverine Asset Management’s Portfolio NLSPW Stock Details NLSPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-245,000	Closed	-$3.19K	–	1705
2024 Q4	$3.19K	Buy	+245,000	New	+$2.99K	﹤0.01%	1452

Other funds holding NLSPW

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Wolverine Asset Management's NLSPW Position: Q1 2025 in Review

Wolverine Asset Management sold out of NLS Pharmaceutics Warrant (NLSPW) in Q1 2025, closing a stake of 245,000 shares — an estimated $3.19K sold.

Wolverine Asset Management first reported a position in NLSPW in Q4 2024 and held it in 1 quarter. The position peaked at $3.19K in Q4 2024. 3 funds tracked by Wall St. Rank hold NLSPW as of Q1 2025.

Wolverine Asset Management reported no remaining NLS Pharmaceutics Warrant position as of Q1 2025 after selling out during the quarter.
Wolverine Asset Management sold 245,000 NLS Pharmaceutics Warrant shares in Q1 2025, an estimated $3.19K.
Wolverine Asset Management first reported a position in NLS Pharmaceutics Warrant in Q4 2024 and held it in 1 quarter.
Wolverine Asset Management's NLS Pharmaceutics Warrant position peaked at $3.19K in Q4 2024.
3 funds tracked by Wall St. Rank held NLS Pharmaceutics Warrant as of Q1 2025.

Based on Wolverine Asset Management's 13F filing for Q1 2025, filed 12 May 2025.